Navigation Links
ClearCanvas Releases First Commercial Version of Popular Clinical Radiology Workstation; PACS and RIS to Follow
Date:4/15/2011

TORONTO, April 15, 2011 /PRNewswire/ -- ClearCanvas Inc., an innovative medical imaging informatics company, today announced the commercial release of their clinical radiology workstation product, ClearCanvas Workstation, Clinical Edition. This marks the first time ClearCanvas has offered a commercial version of their widely accepted Workstation software, previously only offered as an open source application.

ClearCanvas open source software has been employed for over five years, with more than 14,000 worldwide users in a number of clinical settings. With such extensive application, commercial versions of the products were an obvious next step. ClearCanvas RIS/PACS recently received FDA 510(k) clearance. This important regulatory status allows for commercial distribution of the ClearCanvas software.

The ClearCanvas Workstation, Clinical Edition is available for purchase from the eStore on the ClearCanvas website as well as through a small but rapidly growing number of resellers worldwide.

ClearCanvas expects to release a commercial version of their PACS software suite in Q2 2011 with the commercial release of their RIS following in Q4 2011. Additional versions of the Workstation are already planned for 2011; product upgrades and technical support are included free of charge during the first license year. ClearCanvas will continue to release new versions of their open source software as well.  

"Open source products have always been an integral part of who we are and that will not change," states Norman Young, company President and Founder. "At the same time, we also recognize how important it is to create a vibrant commercial ecosystem by bringing our products to different markets around the world. We are extremely excited to offer what so many of our users have been asking for -- a commercial, FDA-cleared version of our very popular Workstation product."

About ClearCanvas Inc.

ClearCanvas Inc. develops innova
'/>"/>

SOURCE ClearCanvas Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. BioLegend Releases Brilliant Violet 421™ Antibody Conjugates For Advanced Flow Cytometry Applications.
2. ACO Proposed Rule Simplified: MedeAnalytics Releases Comprehensive White Paper
3. Clontech Laboratories, Inc. Releases the SMARTer™ Ultra Low RNA Kit for Illumina® Sequencing
4. OriGene Releases Bioactive Full-length Human MTOR Protein
5. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2011
6. Waters Releases NuGenesis SDMS 7.1 Validated to Support Windows 7 and Empower 3 CDS
7. OriGene Releases 1500 TrueMAB™ Monoclonal Antibodies
8. ACTE Releases Issue Brief Outlining Critical Role CTE Plays in Worker Retraining
9. Elsevier Releases Image Search; New SciVerse ScienceDirect Feature Enables Researchers to Quickly Find Reliable Visual Content
10. Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information
11. Kibow Biotech Releases Results of Pilot Scale Study of Its Probiotic Formulation for Kidney Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/25/2015)... Francisco, CA (PRWEB) March 25, 2015 ... Support for Novel Mechanism of Action in Neuromuscular ... 25, 2015 – Cytokinetics, Incorporated (Nasdaq: CYTK) announced ... fast skeletal muscle troponin activator tirasemtiv in the ... a Phase IIa “Evidence of Effect” or hypothesis-generating ...
(Date:3/25/2015)... and the HAGUE, Netherlands , March ... of LES Stimulation therapy for chronic gastro-esophageal reflux disease ... Surgery [ Surgery . 2015; 157(3):556-567 ], ... minimally-invasive therapy. The study included 25 ... 11 years and taking prescribed daily proton pump inhibitor ...
(Date:3/25/2015)... COLLEGE PARK, Md. , March 25, 2015 ... of two years of intense research by scientists ... University of Maryland and represent a breakthrough in ... an assistant professor in the Department of Animal & ... faculty research assistant in ANSC, successfully produced genome-edited ...
(Date:3/25/2015)... , March 25, 2015  CASI Pharmaceuticals, Inc. ... the acquisition, development and commercialization of innovative therapeutics addressing ... market with a commercial focus on China ... 2 trial of its target therapy drug candidate ENMD-2076 ... of Chinese Academy of Medical Sciences in ...
Breaking Biology Technology:Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 3Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 4Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 5Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 6EndoStim LES Stimulation therapy demonstrates long term safety and efficacy results in treating reflux patients 2EndoStim LES Stimulation therapy demonstrates long term safety and efficacy results in treating reflux patients 3University of Maryland Researchers Successfully Produce Genome-edited Pigs Using Revolutionary Technology 2CASI Pharmaceuticals Announces Initiation Of A Phase 2 Trial With ENMD-2076 In Triple-Negative Breast Cancer In China 2CASI Pharmaceuticals Announces Initiation Of A Phase 2 Trial With ENMD-2076 In Triple-Negative Breast Cancer In China 3CASI Pharmaceuticals Announces Initiation Of A Phase 2 Trial With ENMD-2076 In Triple-Negative Breast Cancer In China 4CASI Pharmaceuticals Announces Initiation Of A Phase 2 Trial With ENMD-2076 In Triple-Negative Breast Cancer In China 5
... Informed Medical Communications (IMC), a leading provider of ... announced the appointment of Kerry Crawford to the ... this critical role, Kerry will lead operations and ... relationship management systems. This key addition is ...
... sweeteners partner to produce world,s first probiotic-enhanced ... baking aisleINDIANAPOLIS, March 3 Ganeden ... the patented probiotic strain GanedenBC30, today announced ... , an Indianapolis-based leading innovator of health ...
... Inc.,(OTC Bulletin Board: CLXS), a leading developer of ... launch of the world,s first,CTSA Experts Platform drawing ... more than 60,000 life science researchers. The platform ... of the Clinical Translational Science,Awards (CTSA,s) from the ...
Cached Biology Technology:Informed Medical Communications Appoints New Senior Manager, Strategic Operations 2Ganeden Biotech and Heartland Sweeteners to Produce Probiotic Sweetener 2Ganeden Biotech and Heartland Sweeteners to Produce Probiotic Sweetener 3Collexis Connects the NIH Clinical and Translational Science Award Programs with CTSA Expert Platform 2Collexis Connects the NIH Clinical and Translational Science Award Programs with CTSA Expert Platform 3
(Date:3/11/2015)... and Markets ( http://www.researchandmarkets.com/research/3p32qm/access_control ) has announced ... Product, Application & By Geography - Global Forecast & ... This report predicts that the access control ... with an estimated CAGR of 10.6%. The ... as contact cards & readers, contactless cards & readers, ...
(Date:3/10/2015)... NEW YORK , March 10, 2015  Continuing ... and the Unexpected, Hammacher Schlemmer introduces The Eye ... user,s identity before granting access to secure websites or ... trusted to verify travelers at international borders, the device ... 240 distinctive pattern points of the iris, converting them ...
(Date:3/10/2015)... Utah , March 10, 2015   Tute ... interpretation, has been selected by next-generation sequencing company ... of whole exome and targeted gene panel interpretation. ... provider, has adopted the most current technologies to support ... genetic research. The company offers two types of exome ...
Breaking Biology News(10 mins):Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 3
... will gather in Maputo, Mozambique, 21-24 October, for the ... Science (ICSU)the first time an ICSU GA will be ... scientists from around the world will come together at ... can contribute to solving some of the most pressing ...
... green may be heart healthy if the green ... at Penn State who conducted the first study ... "We investigated mechanisms of action to explain the ... K. Gebauer, recent Penn State Ph.D. recipient, currently ...
... Boulder, CO, USA Counting on wetlands restoration projects ... is likely to be a "losing battle" that provides ... for their future, says a researcher from Western Carolina ... Gulf of Mexico this fall, the media has been ...
Cached Biology News:Global science community to gather in Mozambique 2Researchers study how pistachios may improve heart health 2Wetlands restoration not a panacea for Louisiana coast 2Wetlands restoration not a panacea for Louisiana coast 3
Human peripheral blood CD19+ B cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Monocytes, B Cells, NK Cells and Stem Cells...
Umbilical cord blood mononuclear cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood MNCs and T Cells...
Human plasmacytoid dendritic cells, BDCA-4+, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Dendritic Cells and EPCs...
Umbilical cord blood basophils, For immunohistochemistry (IHC)...
Biology Products: